Novozymes A/S (OTCMKTS: NVZMF) is a global leader in biological solutions, specializing in the development and production of industrial enzymes and microorganisms. The company’s products are designed to improve the efficiency and sustainability of a wide range of industries, including agriculture, bioenergy, food and beverage, household care, and textiles. By leveraging biotechnology, Novozymes helps customers reduce resource consumption, lower environmental impact, and optimize process performance.
Novozymes offers an extensive portfolio of enzyme products and microbial solutions that address specific industrial challenges such as starch conversion, biofuel production, and ingredient functionality in food processing. In addition to core enzyme products, the company provides digital tools and application support to integrate its solutions seamlessly into customer operations. This combination of technical expertise and tailored service models has positioned Novozymes as a trusted partner across multiple geographies.
Founded as part of Novo Nordisk’s enzyme division and established as an independent company in 2000, Novozymes is headquartered in Bagsværd, Denmark. It operates production and research facilities in Europe, the Americas and the Asia-Pacific region, serving customers in more than 100 countries. The company invests heavily in a global R&D network focused on protein engineering, fermentation technology and bioinnovation platforms.
Under the leadership of President and CEO Ester Baiget, Novozymes continues to advance its sustainability agenda by developing solutions that support circular economy principles and climate goals. The company collaborates with industry partners, academic institutions and non-governmental organizations to accelerate progress toward reduced waste, lower carbon emissions and improved resource stewardship worldwide.
AI Generated. May Contain Errors.
